Puppies and dogs not vaccinated against parvovirus face the greatest risk of contracting the deadly, highly contagious disease, according to the AVMA, which notes there is no pharmaceutical treatment available. But that could soon change, as Avianax has developed a goose antibody treatment. Veterinarian and Chief Science Officer Darin Meulebroeck says dogs who received the new therapy recovered in 24 hours, and although two treated dogs died, diagnosis was delayed in those cases. The USDA granted Avianax a permit to ship the product to some veterinarians for field testing.
Published in Brief: